Factors produced by activated macrophages reduce accumulation of Alzheimer's β-amyloid protein in vascular smooth muscle cells

Brain Research

Volumn 760, Issue 1-2, 1997, Pages 255-260

  Mazur Kolecka, Bozena ^a,b   Frackowiak, Janusz ^a   Le Vine III, Harry ^c   Haske, Taraneh ^c   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c PFIZER INC   (United States)

Author keywords

Amyloid accumulation; Amyloid precursor protein processing; Monokines; Smooth muscle cell

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DOG; IMMUNOCOMPETENT CELL; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; VASCULAR AMYLOIDOSIS; VASCULAR SMOOTH MUSCLE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CATTLE; DOGS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030738567     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00327-2     Document Type: Article

References (34)

1. Aisen P.S., Davis K.L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry. 151:1994;1105-1113.
2. Araujo D.M., Lapchak P.A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience. 61:1994;745-754.
3. 2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
4. Brandan E., Inestrosa N. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen. Pharmacol. 24:1993;1063-1068.
5. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. (USA). 89:1992;10075-10078.
6. Cantini M., Carraro U. Macrophage-released factor stimulates selectively myogenic cells in primary muscle culture. J. Neuropathol. Exp. Neurol. 54:1995;121-128.
7. Chao C.C., Shuxian H.U., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via nitric oxide mechanisms. J. Immunol. 149:1992;2736-2741.
8. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444.
9. Colton C.A., Gilbert D.L. Production of superoxide anions by CNS macrophage, the microglia. FEBS Lett. 223:1987;284-288.
10. Eikelenboom P., Hack C.E., Rozemuller J.M., Stam F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. (B). 56:1989;259-262.
11. Frackowiak J., Wisniewski H.M., Wegiel J., Merz G.S., Iqbal K., Wang K.S. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. (Berl.). 84:1992;225-233.
12. Frackowiak J., Zoltowska A., Wisniewski H.M. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J. Neuropathol. Exp. Neurol. 53:1994;637-645.
13. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carroll R.T., Emmerling M.R., Kim K.S. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res. 676:1995;225-230.
14. J. Frackowiak, B. Mazur-Kolecka, J. Wegiel, K.S. Kim, H.M. Wisniewski, Culture of canine vascular myocytes as a model to study production and accumulation of β-protein by cells involved in amyloidogenesis, in: K. Iqbal, J.A. Mortimer, B. Winblad, H.M. Wisniewski (Eds.), Research Advances in Alzheimer's Disease and Related Disorders, Wiley, Chichester, 1995, pp. 747-754.
15. Frederickson R.C.A., Brunden K.R. New opportunities in AD research roles of immunoinflammatory responses and glia. Alzheimer Dis. Assoc. Disord. 8:1994;159-165.
16. Giulian D. Microglia, cytokines, and cytotoxins: modulators of cellular responses after injury to the central nervous system. J. Immunol. Immunopharmacol. 10:1990;15-21.
17. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. (USA). 86:1989;7606-7610.
18. Haass C., Schlossmacher M.G., Hung A., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
19. Haass C., Selkoe D.J. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 75:1993;1039-1042.
20. Lahiri D.K., Nall C.K. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Mol. Brain Res. 32:1995;233-240.
21. Libby P., Warner S.J.C., Friedan G.B. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81:1988;487-498.
22. Mazur-Kolecka B., Frackowiak J., Wisniewski H.M. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells. Brain Res. 698:1995;217-222.
23. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107:1989;341-346.
24. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E.G. Microglia in degenerative neurological disease. Glia. 7:1993;84-92.
25. Perry V.H., Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci. 11:1988;273-277.
26. Rozemuler J.M., Van der Valk P., Eikelenboom P. Activated microglia and cerebral amyloid deposits in Alzheimer's disease. Res. Immunol. 143:1992;646-649.
27. Selkoe D.J. Cell biology of the amyloid β-protein precursor and the mechanisms of Alzheimer's disease. Annu. Rev. Cell Biol. 10:1994;373-403.
28. Shaffer L.M., Dority M.D., Gupta-Bansal R., Frederickson R.C.A., Younkin S.G., Brunden K.R. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol. Aging. 16:1995;737-745.
29. Tooyama I., Kimura H., Akiyama H., McGeer P.L. Reactive microglia express class I and class II major histocompatibility complex antigen in Alzheimer's disease. Brain Res. 523:1990;273-280.
30. Wisniewski H.M., Wegiel J. Migration of perivascular cells into the neuropil and their involvement in β-amyloid plaque formation. Acta Neuropathol. (Berl.). 85:1993;586-595.
31. Wisniewski H.M., Frackowiak J., Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci. Lett. 183:1995;120-123.
32. Vasilakos J.P., Carrol R.T., Emmerling M.R., Doyle P.D., Davis R.E., Kim K.S., Shivers B.D. Interleukin-1β dissociates β-amyloid precursor protein and β-amyloid peptide secretion. FEBS Lett. 354:1994;89-292.
33. Yamaguchi H., Ishiguro K., Sugihara S., Nakazato Y., Kawarabayashi T.S., Hirai S. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol. (Berl.). 88:1994;413-419.
34. Yue T.L., Wang X.K., Olson B., Feuerstein G. Interleukin-1β (IL-1β) induces transforming growth factor-β1 (TGF-β1) production by rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 204:1994;1186-1192.